Use of Air Purifiers to Improve Respiratory Health in Children

April 4, 2023 updated by: University of Liverpool

Use of Air Purification Devices in the Homes of Children and Young People to Improve Respiratory Health - a Pilot Study

The goal of this pilot study is to investigate if installing an air purifier in the homes of children and young people with asthma improves their asthma outcomes.

The main questions it aims to answer are:

  • Does installing an air purifier in the homes of children and young people with asthma improve their asthma outcomes
  • Is the use of an air purifier in the home acceptable to children and young people and their families?

Children and young people with asthma attending our clinic will be selected at random to be invited to take part. For those that take part, an air purifier (Rensair Ltd. - Rensair Compact) will be installed in their home for a one-year period. Data will be collected on numbers of asthma attacks, rescue oral steroids, quality of life, symptoms, lung function at the beginning and at three-monthly intervals throughout the study period. The acceptability to children and young people and their families taking part in this study of using an air purifier in their home will also be assessed.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 5 to 15 years old
  • Attend the asthma clinic in our hospital
  • Have a confirmed physician-diagnosis of asthma from the asthma clinic
  • Live in mainland England (this is due to delivery of the air purification units and also associated maintenance of them)

Exclusion Criteria:

  • Nil specific other than not meeting inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Installation of air purifier (Rensair Ltd - Rensair Compact)
Rensair Compact air purifier unit will be installed in the homes of all children/young people participating in this study for a period of one-year.
Installation of Rensair Compact air purifier (Rensair Ltd.) in the homes of children/young people participating in this study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of asthma exacerbations (asthma attacks)
Time Frame: 12 months
Asthma attacks and unscheduled healthcare visits due to acute asthma (including ED attendance, admission, GP/primary care attendance) - assessed by questionnaire and hospital-recorded attendances/admissions
12 months
Number of rescue oral steroid courses
Time Frame: 12 months
Number of rescue oral steroid courses - assessed by questionnaire and prescription data
12 months
Quality of life - mini paediatric asthma quality of life questionnaire score
Time Frame: 12 months
Quality of life using mini paediatric asthma quality of life questionnaire - the higher the score the better the quality of life
12 months
Asthma control test score
Time Frame: 12 months
Asthma control test (ACT) or child asthma control test score (cACT) - depending on age of participant - the higher the score the better the asthma control
12 months
Amount of asthma reliever medication use per week
Time Frame: 12 months
Amount of use of asthma reliever medication use over a one week period (assessed as a categorical value)
12 months
Number of school days absent due to asthma
Time Frame: 12 months
Number of school days missed due to asthma - assessed by questionnaire
12 months
Number of parent/carer work days missed due to their child's asthma
Time Frame: 12 months
Number of work days missed due to child's asthma - assessed by questionnaire
12 months
Forced expired volume in one second (FEV1)
Time Frame: 12 months
Spirometry measurements using ERS/ATS criteria and Global Lung Initiative Reference z-score
12 months
Forced vital capacity (FVC)
Time Frame: 12 months
Spirometry measurements using ERS/ATS criteria and Global Lung Initiative Reference z-score
12 months
FEV1:FVC
Time Frame: 12 months
Spirometry measurements using ERS/ATS criteria and Global Lung Initiative Reference z-score
12 months
Measurement of fraction of exhaled nitric oxide (FeNO)
Time Frame: 12 months
Fraction of exhaled nitric oxide measurements
12 months
Acceptability to children and families participating of using an air purifier in their home
Time Frame: 12 months
Acceptability to children and young people and their families taking part in the study in terms of use of air purifier in their homes - assessed by questionnaire
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2023

Primary Completion (Anticipated)

April 1, 2024

Study Completion (Anticipated)

April 1, 2024

Study Registration Dates

First Submitted

March 22, 2023

First Submitted That Met QC Criteria

April 4, 2023

First Posted (Actual)

April 18, 2023

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 4, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • UoL001754

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma in Children

Clinical Trials on Rensair Compact air purifier unit

3
Subscribe